Cargando…

Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model

BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease afflicting about one third of the world’s population and 30 % of the US population. It is induced by consumption of high-lipid diets and is characterized by liver inflammation and subsequent liver pathology. Obesity and...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Do-Geun, Krenz, Antje, Toussaint, Leon E., Maurer, Kirk J., Robinson, Sudie-Ann, Yan, Angela, Torres, Luisa, Bynoe, Margaret S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700622/
https://www.ncbi.nlm.nih.gov/pubmed/26728181
http://dx.doi.org/10.1186/s12974-015-0467-5
_version_ 1782408350274682880
author Kim, Do-Geun
Krenz, Antje
Toussaint, Leon E.
Maurer, Kirk J.
Robinson, Sudie-Ann
Yan, Angela
Torres, Luisa
Bynoe, Margaret S.
author_facet Kim, Do-Geun
Krenz, Antje
Toussaint, Leon E.
Maurer, Kirk J.
Robinson, Sudie-Ann
Yan, Angela
Torres, Luisa
Bynoe, Margaret S.
author_sort Kim, Do-Geun
collection PubMed
description BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease afflicting about one third of the world’s population and 30 % of the US population. It is induced by consumption of high-lipid diets and is characterized by liver inflammation and subsequent liver pathology. Obesity and consumption of a high-fat diet are known to increase the risk of Alzheimer’s disease (AD). Here, we investigated NAFLD-induced liver inflammation in the pathogenesis of AD. METHODS: WT and APP-Tg mice were fed with a standard diet (SD) or a high-fat diet (HFD) for 2, 5 months, or 1 year to induce NAFLD. Another set of APP-Tg mice were removed from HFD after 2 months and put back on SD for 3 months. RESULTS: During acute phase NAFLD, WT and APP-Tg mice developed significant liver inflammation and pathology that coincided with increased numbers of activated microglial cells in the brain, increased inflammatory cytokine profile, and increased expression of toll-like receptors. Chronic NAFLD induced advanced pathological signs of AD in both WT and APP-Tg mice, and also induced neuronal apoptosis. We observed decreased brain expression of low-density lipoprotein receptor-related protein-1 (LRP-1) which is involved in β-amyloid clearance, in both WT and APP-Tg mice after ongoing administration of the HFD. LRP-1 expression correlated with advanced signs of AD over the course of chronic NAFLD. Removal of mice from HFD during acute NAFLD reversed liver pathology, decreased signs of activated microglial cells and neuro-inflammation, and decreased β-amyloid plaque load. CONCLUSIONS: Our findings indicate that chronic inflammation induced outside the brain is sufficient to induce neurodegeneration in the absence of genetic predisposition. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-015-0467-5) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-4700622
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-47006222016-01-06 Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model Kim, Do-Geun Krenz, Antje Toussaint, Leon E. Maurer, Kirk J. Robinson, Sudie-Ann Yan, Angela Torres, Luisa Bynoe, Margaret S. J Neuroinflammation Research BACKGROUND: Non-alcoholic fatty liver disease (NAFLD) is a chronic liver disease afflicting about one third of the world’s population and 30 % of the US population. It is induced by consumption of high-lipid diets and is characterized by liver inflammation and subsequent liver pathology. Obesity and consumption of a high-fat diet are known to increase the risk of Alzheimer’s disease (AD). Here, we investigated NAFLD-induced liver inflammation in the pathogenesis of AD. METHODS: WT and APP-Tg mice were fed with a standard diet (SD) or a high-fat diet (HFD) for 2, 5 months, or 1 year to induce NAFLD. Another set of APP-Tg mice were removed from HFD after 2 months and put back on SD for 3 months. RESULTS: During acute phase NAFLD, WT and APP-Tg mice developed significant liver inflammation and pathology that coincided with increased numbers of activated microglial cells in the brain, increased inflammatory cytokine profile, and increased expression of toll-like receptors. Chronic NAFLD induced advanced pathological signs of AD in both WT and APP-Tg mice, and also induced neuronal apoptosis. We observed decreased brain expression of low-density lipoprotein receptor-related protein-1 (LRP-1) which is involved in β-amyloid clearance, in both WT and APP-Tg mice after ongoing administration of the HFD. LRP-1 expression correlated with advanced signs of AD over the course of chronic NAFLD. Removal of mice from HFD during acute NAFLD reversed liver pathology, decreased signs of activated microglial cells and neuro-inflammation, and decreased β-amyloid plaque load. CONCLUSIONS: Our findings indicate that chronic inflammation induced outside the brain is sufficient to induce neurodegeneration in the absence of genetic predisposition. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1186/s12974-015-0467-5) contains supplementary material, which is available to authorized users. BioMed Central 2016-01-05 /pmc/articles/PMC4700622/ /pubmed/26728181 http://dx.doi.org/10.1186/s12974-015-0467-5 Text en © Kim et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Kim, Do-Geun
Krenz, Antje
Toussaint, Leon E.
Maurer, Kirk J.
Robinson, Sudie-Ann
Yan, Angela
Torres, Luisa
Bynoe, Margaret S.
Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
title Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
title_full Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
title_fullStr Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
title_full_unstemmed Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
title_short Non-alcoholic fatty liver disease induces signs of Alzheimer’s disease (AD) in wild-type mice and accelerates pathological signs of AD in an AD model
title_sort non-alcoholic fatty liver disease induces signs of alzheimer’s disease (ad) in wild-type mice and accelerates pathological signs of ad in an ad model
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4700622/
https://www.ncbi.nlm.nih.gov/pubmed/26728181
http://dx.doi.org/10.1186/s12974-015-0467-5
work_keys_str_mv AT kimdogeun nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT krenzantje nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT toussaintleone nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT maurerkirkj nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT robinsonsudieann nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT yanangela nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT torresluisa nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel
AT bynoemargarets nonalcoholicfattyliverdiseaseinducessignsofalzheimersdiseaseadinwildtypemiceandacceleratespathologicalsignsofadinanadmodel